LONDON, June 11, 2018 /PRNewswire/ --
Discover Prospects for Medical Research and TherapeuticUses, Including Human Tissues, Stem Cells (Adult Stem Cells, Umbilical Cord), Other applications (DNA, RNA, body fluids), Leading Biobanking Companies and Key Geographies
Biobanking - our new study reveals trends, R&D progress, and predicted revenues
(Logo: http://mma.prnewswire.com/media/523989/Visiongain_Logo.jpg ) Where is the Biobanking market heading? If you are involved in this sector you must read this brand-new report. Visiongain's report shows you the potential revenues streams to 2028, assessing data, trends, opportunities and business prospects there.
Discover How to Stay Ahead Our 266-page report provides 145 tables, charts, clearly illustrating the data presented in this research. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted drug sales at overall world market regional level, as well as giving a deep insight into the pipeline for Biobanking. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Biobanking market. See how to exploit these opportunities.
Forecasts to 2028 and other analyses reveal the commercial prospects In addition to revenue forecasting to 2028, our new study provides you with recent results, R&D overview, growth rates, and market shares. You will find original analyses, with business outlooks and developments. Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.
Discover sales predictions for the world market and following Biobanking Submarkets:
Biobanking for Research: Human Tissue: - Commercial - Public Stem Cells Others (DNA, Blood fluids etc.)
Biobanking for Therapeutic Use: Umbilical Cord Banking Adult Stem Cell Banking
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 12 leading national markets: US Germany France The UK Spain Italy The Netherlands Japan China India Brazil Russia RoW
Our analysis shows activities of biobanks, including these organisations: Stemgent Biopta BioServe Coriell Institute for Medical Research Cord Blood America Cryo-Cell International.
And other companies, including these: China Cord Blood Corp LifebankUSA ViaCord Cord Blood Registry Biogenea Pharmaceuticals StemLife Caladrius Biosciences.
There will be growth in both established and in developing countries. Our analyses show that the both developed and developing markets, China, India and the US in particular, will continue to achieve high revenue growth to 2028.
Leading companies and the potential for market growth Overall world revenue for Biobanking will surpass $35bn in 2023, our work calculates. This will be driven by the use of biobanking in drug development and medical research, as well as the expected rise in number of commercial biobanks over the forecast period
Our work identifies which organisations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How the Biobanking Market report helps you In summary, our 266-page report provides you with the following knowledge: Revenue forecasts to 2028 for the Biobanking market and Leading Submarkets - discover the industry's prospects, finding the most lucrative places for investments and revenues Revenue forecasts to 2028 for 12 of the leading national markets - US, Germany, France, UK, Italy, Spain, Netherlands, Japan, Russia, China, India, Brazil Discussion of what stimulates and restrains companies and the market Prospects for established firms and those seeking to enter the market - including company profiles for 16 companies involved in commercial biobanking and biobanking for therapeutic use
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else With our survey you are less likely to fall behind in knowledge or miss opportunity. See how you could benefit your research, analyses, and decisions. Also see how you can save time and receive recognition for commercial insight.
Visiongain's study is for everybody needing commercial analyses for the Biobanking market and leading companies. You will find data, trends and predictions.
Get our report today Biobanking Market Forecasts 2018-2028: Discover Prospects for Medical Research and Therapeutic Uses, Including Human Tissues, Stem Cells (Adult Stem Cells, Umbilical Cord), Other applications (DNA, RNA, body fluids), Leading Biobanking Companies and Key Geographies. Avoid missing out - get our report now
To request a report overview of this report please contact Sara Peerun at email@example.com or refer to our website : https://www.visiongain.com/Report/2204/Biobanking-Market-Forecasts-2018-2028
Abbott Laboratories AKH Biobank AllCells American CryoStem American Type Culture Collection Analytical Biological Services ARUP Laboratories ASPREE Healthy Ageing Biobank Assure Immune Asterand AstraZeneca Aurora Biomed Auto scribe Informatics Bangalore Brain Bank Barts Gynae Tissue Bank Bayer BBMRI Beckman Coulter BINDER Bio Fortis Bio Life Solutions Bio Repository Resources BioCision Biogenea Biomatrica Biopta BioreclamationIVT BioRep BioServe Biotechnologies BioSHARE Biovault Technical BIOVIA BrainNet Europe Bristol-Myers Squibb Brooks Automation (acquired Bio Storage Technologies) Brooks Life Science Systems Caladrius Biosciences Cambridge Biomedical Research Centre Cancer Genetics Inc CARTaGENE CCLG Tissue Bank Cells4Life Celltex Therapeutics Cellular Dynamics International Inc Cesca Therapeutics China Cord Blood Corp. China Kadoorie Biobank CLB/Amsterdam Medical Center CMD Biobank CONCOR CorCell Cord Blood America Cord Life CORE Informatics Coriell Institute for Medical Research Cryo Bio System Cryo-Cell Cryo-Cell International Cryogene Lab CryoLogic Cryo-Save Cureline Custom Biogenic Systems Cybrdi DeCODE Genetics (Amgen) Eli Lilly Eli Lilly ENGAGE Eppendorf Esco ESFRI Fisher Bio Services FluidX Future Health Biobank GE Healthcare SeqWright Genomic Services GEN2PHEN Gilson GlaxoSmithKline Haier Biomedical Hamilton Robotics Hamilton Storage Technologies Hospital Necker Paris Hudson Robotics Human Longevity Inc Hungarian Biobank Huntington Disease Biobank In biomed Indivumed Infectious Disease Biobank IntegenX International Stem Cell Corporation Kaiser Permanente King's College London Tissue Bank Lab ware LABVANTAGE Leiden Longevity Leiden University Medical Center Life Bank USA Life Gene Life Lines Biobank Malm? Microbiology Biobank Merck Micronics Mitochondrial Disease Biobank NESDA Novare Biologistics Novartis Ocimum Bio solutions OnCore UK Organisation for Economic Co-operation and Development (OECD) OriGene Pacific Bio Storage PALGA Panasonic Biomedical Parelsnoer PerkinElmer Pfizer Pharma Cells Pop-Gen National Cohort Precious Cells Precision Bio services PrecisionMed PREVEND Progenicyte ProMedDx ProteoGenex Qiagen Riken BRC Cell Bank Roche Sapien Biosciences Sc้il Smart Cells StarLIMS Steelgate Stem Life Stem Save Stemcyte System Biosciences Taiyo Nippon Sanso TAP Bio systems (now owned by Sartorius Stedim Biotech) TCG Life Sciences Tissue Bank Tecan Thermo Fisher Scientific TISS-EU Project Tissue Solutions TTP Labtech UCL Biobank US Biomax Via Cord Virgin Health Bank
To see a report overview please e-mail Sara Peerun on firstname.lastname@example.org
Subscribe to our Free Newsletters!